Chapter 1 Cancer Drugs Market Overview
1.1 Cancer Drugs Definition
1.2 Global Cancer Drugs Market Size Status and Outlook (2016-2030)
1.3 Global Cancer Drugs Market Size Comparison by Region (2016-2030)
1.4 Global Cancer Drugs Market Size Comparison by Type (2016-2030)
1.5 Global Cancer Drugs Market Size Comparison by Application (2016-2030)
1.6 Global Cancer Drugs Market Size Comparison by Sales Channel (2016-2030)
1.7 Cancer Drugs Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Cancer Drugs Market Segment Analysis by Player
2.1 Global Cancer Drugs Sales and Market Share by Player (2019-2021)
2.2 Global Cancer Drugs Revenue and Market Share by Player (2019-2021)
2.3 Global Cancer Drugs Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Cancer Drugs Market Segment Analysis by Type
3.1 Global Cancer Drugs Market by Type
3.1.1 Chemotherapy
3.1.2 Targeted Therapy
3.1.3 Immunotherapy
3.1.4 Hormonal Therapy
3.1.5 Others
3.2 Global Cancer Drugs Sales and Market Share by Type (2016-2021)
3.3 Global Cancer Drugs Revenue and Market Share by Type (2016-2021)
3.4 Global Cancer Drugs Average Price by Type (2016-2021)
3.5 Leading Players of Cancer Drugs by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Cancer Drugs Market Segment Analysis by Application
4.1 Global Cancer Drugs Market by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory/Lung Cancer
4.2 Global Cancer Drugs Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Cancer Drugs by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Cancer Drugs Market Segment Analysis by Sales Channel
5.1 Global Cancer Drugs Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Cancer Drugs Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Cancer Drugs by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Cancer Drugs Market Segment Analysis by Region
6.1 Global Cancer Drugs Market Size and CAGR by Region (2016-2030)
6.2 Global Cancer Drugs Sales and Market Share by Region (2016-2021)
6.3 Global Cancer Drugs Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Cancer Drugs Market Share by Type
6.4.3 North America Cancer Drugs Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Cancer Drugs Market Share by Type
6.5.3 Europe Cancer Drugs Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Cancer Drugs Market Share by Type
6.6.3 Asia-Pacific Cancer Drugs Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Cancer Drugs Market Share by Type
6.7.3 South America Cancer Drugs Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Cancer Drugs Market Share by Type
6.8.3 Middle East & Africa Cancer Drugs Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Cancer Drugs Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Novartis
7.3 Celgene
7.4 Bristol-Myers Squibb
7.5 Amgen
7.6 Johnson & Johnson
7.7 Pfizer
7.8 Takeda
7.9 Eli Lilly
7.10 AstraZeneca
7.11 Astellas
7.12 Merck & Co.
7.13 Sanofi
7.14 Bayer
7.15 Biogen Idec
7.16 Eisai
7.17 Teva
7.18 Otsuka
7.19 Merck KGaA
7.20 Ipsen
7.21 AbbVie
7.22 Gilead Sciences
Chapter 8 Upstream and Downstream Analysis of Cancer Drugs
8.1 Industrial Chain of Cancer Drugs
8.2 Upstream of Cancer Drugs
8.3 Downstream of Cancer Drugs
Chapter 9 Development Trend of Cancer Drugs (2022-2030)
9.1 Global Cancer Drugs Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Cancer Drugs Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Cancer Drugs Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Cancer Drugs Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Cancer Drugs Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
